Anti-Viral Drugs Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global <strong>Anti</strong>-<strong>Viral</strong> <strong>Drugs</strong><br />
<strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation and Forecast,<br />
2016-2026<br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and<br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports and country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive and Transportation<br />
• Electronics, Semiconductor, and ICT<br />
• Retail and Consumer Products<br />
• Industrial Automation and Equipment<br />
• Chemicals & Materials<br />
• Food and Beverages<br />
• Services and Utilities<br />
• Energy, Mining, Oil, and Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Anti</strong>-viral drugs are medicines which are used specially for treating viral infections. Most<br />
anti-viral drugs are used for particular viral infections, similar to antibiotics, while a<br />
broad-spectrum anti-viral drug is effective against a varied range of viruses. <strong>Anti</strong>viral<br />
drugs do not kill their target pathogen, instead they inhibit the development of those<br />
viruses. The global anti-viral drugs market is projected to register a moderate growth rate<br />
in the pharmaceutical market and which is anticipated to increase due to rise in<br />
awareness level, increase in the diseased population and introduction of new drugs with<br />
improved efficacy. Some major patents are reaching their expiry during forecast period,<br />
such as for Combivir, Sustiva, Tenofovir, Tamiflu, Relenza and Telbivudine. The patent<br />
expiries of these blockbuster drugs is expected to trigger generic competition in the<br />
antivirals therapeutics market, which will make the market more competitive. The late<br />
stage pipeline drugs are expected to enter the market, which will positively impact the<br />
market. Most antivirals are considered comparatively harmless to host, and therefore are<br />
used to treat infections. They are different from viricides, which are not used for<br />
medication but can destroy or deactivate virus particles, either outside or inside the<br />
body. The anti-viral drugs are used in the treatment of patients suffering from herpes<br />
viruses, HIV, influenza A and B viruses and the hepatitis B and C viruses.<br />
Request Free Report Sample@<br />
http://www.futuremarketinsights.com/reports/sample/rep-gb-1951
Report Description<br />
<strong>Anti</strong>-viral <strong>Drugs</strong> <strong>Market</strong>: Drivers and Restraints<br />
As of October 2013, according to WHO, there were around 35.3 Mn people globally,<br />
infected with HIV. Therefore, increased viral infection incidences is one of the important<br />
factors that drives the anti-viral drugs market growth. Because of the solid R&D activities,<br />
newer and advanced treatments and formulations, such as vaccines, combination<br />
therapy and others, are being introduced in the market. Hence, strong R&D is one of the<br />
crucial factors in the anti-viral drugs market growth. On the other hand, high risk of<br />
failure, high cost of R&D and therapy, and government austerity are some of threats<br />
expected to hinder the growth of market. These are some factors anticipated to fuel<br />
growth of global anti-viral drugs market within the forecast period of 2016-2026.<br />
However, increasing usage of natural products and high cost of developing drugs are the<br />
key challenges faced by the market.<br />
<strong>Anti</strong>-viral <strong>Drugs</strong> <strong>Market</strong>: Segmentation<br />
The global anti-viral drugs market is classified on the basis of product type, end user and<br />
geography.<br />
Based on product type, the global anti-viral drugs market is segmented into the<br />
following:<br />
• Hepatitis-C antivirals<br />
• HIV antivirals
Report Description<br />
• Herpes antivirals<br />
• Hepatitis-B antivirals<br />
• Influenza antivirals<br />
• Others (Pneumonia, Flu, etc.)<br />
Based on end user, the global anti-viral drugs market is segmented into the following:<br />
• Hospitals<br />
• Clinics<br />
• Ambulatory Surgical Centers<br />
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1951<br />
<strong>Anti</strong>-viral <strong>Drugs</strong> <strong>Market</strong>: Overview<br />
The generic market of anti-viral drugs is presently dominated by products such as<br />
didanosine, zidovudine, lamivudine and stavudine. The biggest driver of overall anti-viral<br />
drugs market is Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome<br />
(HIV/AIDS) therapeutic sales which accounted for more than half the share of the market<br />
2010. At the end of 2012, 9.7 million people in low-income and middle-income countries<br />
were on antiretroviral treatment (ART). According to WHO, in 2012, number of patients<br />
on ART increased by 1.6 Mn, the largest increase in one year. Nearly four out of five
Report Description<br />
people were freshly put on treatment in the sub-Saharan Africa. In 21 African countries<br />
with a high burden of HIV, two out of three people in need are receiving treatment, and<br />
two out of three positive pregnant women are receiving antiretroviral drugs to prevent<br />
HIV transmission to their infants.<br />
<strong>Anti</strong>-viral <strong>Drugs</strong> <strong>Market</strong>: Regional Overview<br />
Region wise, the global anti-viral drugs market is classified into regions namely, North<br />
America, Eastern Europe, Western Europe, Latin America, Japan, Asia-Pacific, Middle East<br />
and Africa. According to WHO, in countries with Major ART scale-up such as Brazil or<br />
China, the death rate among people living with HIV has decreased by 80%. In 2015, in<br />
India the number of people living with HIV were 2.1 Mn and in U.S. the number was<br />
around 1.2 Mn in the year 2013.<br />
Browse Full Report@<br />
http://www.futuremarketinsights.com/reports/anti-viral-drugs-market<br />
<strong>Anti</strong>-viral <strong>Drugs</strong> <strong>Market</strong>: Key Players<br />
Some of the key players in global anti-viral drugs market, which are focusing on general<br />
molecular mechanisms of antiviral drugs rather than therapies for individual viruses,<br />
include Roche, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott, AstraZeneca,<br />
Cipla, Schering-Plough, Johnson & Johnson, Merck & Co and others.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language